IL73585A - Pharmaceutical composition containing an iboga alkaloid for treating opiate addiction - Google Patents

Pharmaceutical composition containing an iboga alkaloid for treating opiate addiction

Info

Publication number
IL73585A
IL73585A IL73585A IL7358584A IL73585A IL 73585 A IL73585 A IL 73585A IL 73585 A IL73585 A IL 73585A IL 7358584 A IL7358584 A IL 7358584A IL 73585 A IL73585 A IL 73585A
Authority
IL
Israel
Prior art keywords
pharmaceutical composition
composition containing
opiate addiction
iboga alkaloid
treating opiate
Prior art date
Application number
IL73585A
Other languages
English (en)
Other versions
IL73585A0 (en
Original Assignee
Lotsof Howard S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lotsof Howard S filed Critical Lotsof Howard S
Publication of IL73585A0 publication Critical patent/IL73585A0/xx
Publication of IL73585A publication Critical patent/IL73585A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL73585A 1983-11-18 1984-11-21 Pharmaceutical composition containing an iboga alkaloid for treating opiate addiction IL73585A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/553,138 US4499096A (en) 1983-11-18 1983-11-18 Rapid method for interrupting the narcotic addiction syndrome

Publications (2)

Publication Number Publication Date
IL73585A0 IL73585A0 (en) 1985-02-28
IL73585A true IL73585A (en) 1990-04-29

Family

ID=24208273

Family Applications (1)

Application Number Title Priority Date Filing Date
IL73585A IL73585A (en) 1983-11-18 1984-11-21 Pharmaceutical composition containing an iboga alkaloid for treating opiate addiction

Country Status (11)

Country Link
US (1) US4499096A (fr)
EP (1) EP0163697B1 (fr)
AU (1) AU576538B2 (fr)
CA (1) CA1237986A (fr)
DE (1) DE3482305D1 (fr)
DK (1) DK156376C (fr)
IE (1) IE58567B1 (fr)
IL (1) IL73585A (fr)
IT (1) IT1178249B (fr)
NO (1) NO844573L (fr)
WO (1) WO1985002115A1 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4587243A (en) * 1985-07-15 1986-05-06 Lotsof Howard S Rapid method for interrupting the cocaine and amphetamine abuse syndrome
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
DE3777805D1 (de) * 1986-11-21 1992-04-30 Glaxo Group Ltd Arzneimittel zur behandlung oder vorbeugung des entzugssyndromes.
US4857523A (en) * 1988-07-18 1989-08-15 Nda International, Inc. Rapid method for attenuating the alcohol dependency syndrome
US5629307A (en) * 1989-10-20 1997-05-13 Olney; John W. Use of ibogaine in reducing excitotoxic brain damage
US5152994A (en) * 1990-05-31 1992-10-06 Lotsof Howard S Rapid method for interrupting or attenuating poly-drug dependency syndromes
ES2264562T3 (es) * 1994-07-25 2007-01-01 Nda International, Inc. Uso de derivados de noribogaina para tratar la dependencia quimica en mamiferos.
DE69635737D1 (de) * 1995-08-08 2006-04-06 Albany Medical College Albany Ibogamin verwandte verbindungen
US5616575A (en) * 1995-12-04 1997-04-01 Regents Of The University Of Minnesota Bioactive tricyclic ibogaine analogs
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
DE69823520T2 (de) 1997-09-04 2005-05-12 Novoneuron, Inc., Miami Noribogain zur behandlung von schmerzen und drogenabhängigkeit
US20030199439A1 (en) * 2002-04-22 2003-10-23 Simon David Lew Compositions of alpha3beta4 receptor antagonists and opioid agonist analgesics
US20030199496A1 (en) * 2002-04-22 2003-10-23 Simon David Lew Pharmaceutical compositions containing alpha3beta4 nicotinic receptor antagonists and methods of their use
US7041320B1 (en) 2002-05-31 2006-05-09 Biotek, Inc. High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
US7157102B1 (en) 2002-05-31 2007-01-02 Biotek, Inc. Multi-layered microcapsules and method of preparing same
US20040266659A1 (en) * 2003-06-27 2004-12-30 Stephen LaBerge Substances that enhance recall and lucidity during dreaming
US20050251442A1 (en) * 2004-05-07 2005-11-10 Joseph Ficalora Consumer incentive system and business method
US8267851B1 (en) 2009-06-16 2012-09-18 James M Kroll Method and apparatus for electrically generating signal for inducing lucid dreaming
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
EP2595632A1 (fr) 2010-07-23 2013-05-29 DemeRx, Inc. Compositions de noribogaïne
EP2481740B1 (fr) 2011-01-26 2015-11-04 DemeRx, Inc. Procédés et compositions pour préparer de la noribogaïne à partir de voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
JP2015500833A (ja) 2011-12-09 2015-01-08 デメレックス， インコーポレイテッド ノルイボガインのリン酸エステル
US20130178618A1 (en) 2012-01-10 2013-07-11 William Allen Boulanger Novel pharmaceutical intermediates and methods for preparing the same
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
CA2858820C (fr) 2012-01-25 2021-08-17 Demerx, Inc. Voacangine synthetique
JP2016508979A (ja) 2012-12-20 2016-03-24 デメレックス， インコーポレイテッド 置換ノルイボガイン
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
US9561233B2 (en) 2014-03-13 2017-02-07 Demerx, Inc. Use of ibogaine for the treatment of pain
CA2989550C (fr) 2014-06-18 2023-08-08 Demerx, Inc. Derives d'indole et de benzofurane halogenes d'isoquinuclidene et procedes pour leur preparation.
US9592239B2 (en) 2014-09-12 2017-03-14 Demerx, Inc. Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake
WO2016126272A1 (fr) * 2015-02-04 2016-08-11 Robert Rand Procédé rapide de réduction des symptômes moteurs et non moteurs de la maladie de parkinson
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
WO2020212951A1 (fr) 2019-04-17 2020-10-22 Compass Pathfinder Limited Procédés de traitement des troubles de l'anxiété, des troubles de la céphalée et des troubles de l'alimentation au moyen de psilocybine
JP2023526515A (ja) 2020-05-20 2023-06-21 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ リソソーム蓄積症をヒスタチンペプチドで処置するための方法
WO2022178099A1 (fr) * 2021-02-17 2022-08-25 The Trustees Of Columbia University In The City Of New York Analogues d'oxa-ibogaïne pour le traitement de troubles liés à l'utilisation de substances
WO2024044756A1 (fr) 2022-08-26 2024-02-29 The Johns Hopkins University Compositions de dendrimères pour l'administration ciblée d'agents thérapeutiques psychédéliques
EP4587019A2 (fr) * 2022-09-14 2025-07-23 The Board of Trustees of the Leland Stanford Junior University Compositions d'alcaloïdes de l'iboga et méthohdes de traitement
US12116372B1 (en) 2023-12-14 2024-10-15 William Allen Boulanger Process for preparing methyl 3-bromo-2-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)propanoate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2877229A (en) * 1959-03-10 Process for the manufacture of indoles

Also Published As

Publication number Publication date
AU576538B2 (en) 1988-09-01
IL73585A0 (en) 1985-02-28
AU3674484A (en) 1985-06-03
CA1237986A (fr) 1988-06-14
DK316485A (da) 1985-07-11
WO1985002115A1 (fr) 1985-05-23
EP0163697A4 (fr) 1986-04-15
DK156376C (da) 1990-01-02
US4499096A (en) 1985-02-12
DK156376B (da) 1989-08-14
DE3482305D1 (de) 1990-06-28
EP0163697A1 (fr) 1985-12-11
EP0163697B1 (fr) 1990-05-23
IE842932L (en) 1985-05-18
IT8449184A1 (it) 1986-05-19
IE58567B1 (en) 1993-10-06
IT8449184A0 (it) 1984-11-19
DK316485D0 (da) 1985-07-11
IT1178249B (it) 1987-09-09
NO844573L (no) 1985-05-20

Similar Documents

Publication Publication Date Title
IL73585A (en) Pharmaceutical composition containing an iboga alkaloid for treating opiate addiction
GB2150832B (en) Analgesic compositions containing buprenorphine
HUT36472A (en) Process for producing inotrpe compositions containing compounds with quinoline scelet
PH20679A (en) Method for stimulating salivation
GB8410240D0 (en) Nitrogen-containing heterocyclic compounds
HUT35515A (en) Process for producing percutane pharmaceutical composition
HUT36139A (en) Process for preparing 13-alpha-alkyl-gonanes and pharmaceutical compositions containing such compounds
EP0249701A3 (en) Method for containing two part composition
YU54884A (en) Apparatus for selfmaking of cigarettes
HUT34984A (en) Process for peneme derivatives
EP0277825A3 (en) Method for purifying hexamethyldisiloxane
PT78321A (en) Process for preparing novel indole-dihydroindole pharmaceutical compounds
YU237283A (en) Process for obtaiing 7-carboxy-methoxy-phenyl-acetamido-3-cephem derivatives
HUT35517A (en) Process for producing pharmaceutical composition
ZA833981B (en) Noroxymorphone compounds,process for preparing such,and pharmaceutical compositions thereof
PT79690A (en) Process for preparing imidazoquinolines containing other heterocyclic groups
PT79650B (en) Process for preparing n-substituted tetrazole-carboxamides compounds
IL73355A (en) Process for purifying fluorocarbons
PT78531B (en) Process for preparing amino-lower alkylpenem compounds and pharmaceutical compositions containing them
YU43662B (en) Process for making beta-lactam compounds
PH24884A (en) Fused heteroalkylene quinolinamines,composition containing said compound and method for use thereof
EP0118286A3 (en) Process for preparing an inhibiting agent
GB2204240B (en) Compositions for treating nicotine addiction.
ZA843779B (en) Composition for treating asthma
HUT34154A (en) Process for preparing substituted diphenyl-azo-methine deruvatives and pharmaceutical compositions containing such compounds

Legal Events

Date Code Title Description
HP Change in proprietorship
HP Change in proprietorship
KB Patent renewed
KB Patent renewed
EXP Patent expired